The Hepatic oncology team reviews for The Lancet the treatment of Hepatocellular carcinoma
Hepatocellular carcinoma is the sixth most prevalent cancer and the third most frequent cause of cancer-related death. The team led by Dr. Jordi B1
Hepatocellular carcinoma is the sixth most prevalent cancer and the third most frequent cause of cancer-related death. The team led by Dr. Jordi B1
Myelofibrosis is a rare spontaneous disease that affects bone marrow progenitor cells. In 2005 researchers discovered that 60% of patients carry an a1
Dr. Francisco Fernandez-Avilés offered on Monday February 20th an IDIBAPS Seminar about stem cell therapy for cardiac repair. He offered a wide persp1
Life expectancy in developed countries has increased leading to a growing prevalence of diseases associated with aging, such as cardiovascular and ne1
DIRECT (DIabetes REsearCh for patient straTification), a consortium funded by the Innovative Medicines Initiative (IMI), announced today the launch o1
Many drinkers who regularly consume large amounts of alcohol are unaware that they are reaching dangerous levels of alcohol intake. At present, accor1
A clinical trial published in The American Journal of Clinical Nutrition (AJCN), headed by doctors and researchers of the Department of Internal Medi1
Three consecutive papers in Nature Protocols, EMBO Journal and Molecular Biology of the Cell position the IDIBAPS group Proliferation and cell signa1